The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17 - sprookjes - yvandenbroek - TriplyDB

The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17

The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17

http://www.wikidata.org/entity/Q34653094

about

CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD AMD and the alternative complement pathway: genetics and functional implications Guidelines for the Management of Wet Age-Related Macular Degeneration: Recommendations from a Panel of Greek Experts Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects Clinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture - Part II Geographic Atrophy and Choroidal Neovascularization in the Same Eye: A Review Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis A survey on computer aided diagnosis for ocular diseases Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema.Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration Animals as models of age-related macular degeneration: an imperfect measure of the truth.Driving and Age-Related Macular Degeneration.A short-duration dark adaptation protocol for assessment of age-related maculopathy Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation.The Nakuru eye disease cohort study: methodology & rationale.Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration.Harmonizing the classification of age-related macular degeneration in the three-continent AMD consortium.Development of a risk score for geographic atrophy in complications of the age-related macular degeneration prevention trial.The complexities underlying age-related macular degeneration: could amyloid beta play an important role?Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography.A Review of Current and Future Management of Geographic Atrophy.Cholesterol in the retina: the best is yet to come.Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age-related macular degeneration.In-depth analyses unveil the association and possible functional involvement of novel RAD51B polymorphisms in age-related macular degeneration.Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case-control samples Cone structure in subjects with known genetic relative risk for AMD.The retinal pigment epithelium in health and disease Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28.Foveal localization in non-exudative AMD using scanning laser polarimetry Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis.Rare and common variants in extracellular matrix gene Fibrillin 2 (FBN2) are associated with macular degeneration.Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration.Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration.Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25.

P2860

Q21090046-1DF781DD-FAB0-4823-B522-17C94E4116B2 Q26744106-217B6AE8-4CDB-413B-8085-7F9214E9A3E2 Q26749615-2FD170AE-B3BF-4192-9B5F-5085830847A0 Q26774188-B73891B7-AAFD-4B03-9E29-AC5AC186D85B Q26864721-CFC032B6-93F8-4D5C-A166-6547A4E1FA01 Q28074640-31033B68-8ED8-4A90-B47D-D5BE76C9B0E8 Q28551885-9273786F-53ED-416E-8B2C-4051A889D5D0 Q28655780-FDE55B29-69FD-4E7E-8D3B-315F194B8218 Q30239897-0DAD8FF2-3BE4-4B3B-87FF-1902F92819AF Q33263472-521FAE00-80A6-4E54-B869-F13AAB602697 Q33339267-3FCD46C5-B7DC-44D9-AC47-4AAE678BC59E Q33359481-E15D63B8-E517-4821-B282-4D59E8CC2BA7 Q33552165-8918862B-E258-4583-81B8-EF03D4F5EA73 Q33565104-FBA10C54-46F0-4B88-AFEC-C99580DFE2DB Q33574618-096CAC61-0753-4C6B-A99E-02E04346AA17 Q33584512-5E6B3BAB-1FD0-4086-8E71-A8F48AAC02FF Q33624678-0B5E5DB3-1AB8-4D44-8741-1361082B9A2B Q33634096-4629AD4B-377B-4738-A1DE-4B0693F12C5F Q33643633-9758314D-0F02-4B4A-B0A3-88E89EBE967E Q33676775-8D3FCD38-799C-4961-8C70-EC5484F58283 Q33702571-082F274A-9B18-4A12-BA82-9615F197B9A2 Q33717538-C55D0C4B-6242-441C-9BE4-D0C52DBA579F Q33734035-A081050B-F5F8-4B38-A546-12019868ABB2 Q33740158-0D49E962-07BF-43B2-ACFB-D0A4321857B9 Q33758267-9883EDA4-AAE8-4CB5-85E6-7F1D6B795112 Q33834227-6B07E0D2-E4ED-4D77-85F8-D6FD5CC7AB7D Q33848714-8502BF92-972F-4E54-911F-F53B0E670A7C Q33950814-79A22527-F927-4926-A80A-408FE181CA42 Q33953252-8B18D0E8-B076-45A8-BE70-B2CED2833900 Q33998365-8F48104A-E581-4768-A0FA-1861D40BDE19 Q34003267-125DEEE6-D779-4EA3-97FB-B420D74D7879 Q34127143-121A6F89-F69A-44D1-8C0C-60C9F6DBAAB0 Q34164826-D92963A8-06CC-45E6-B463-C69070C63068 Q34215917-EA09A8FE-2061-4C3F-B852-2E6252E60B0B Q34216036-47D56B59-8286-4E60-84D8-187D4BE4DC6B Q34307274-BEB9018F-AAF7-4FCF-8CCC-113ACDDC835E Q34395891-D3AA396E-1AB9-4492-A07F-9592C0D8E122 Q34405206-0787063F-ABC8-4F4C-BAD1-435BDDD39F7F Q34476425-E5D19399-2533-4B1D-BBEB-8FEC6091DB8D Q34491990-3B735C20-46E8-4302-B91F-BAAD8514628A

P2860

The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17

http://www.wikidata.org/entity/Q34653094

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

The Age-Related Eye Disease St ...... eneration: AREDS Report No. 17

@ast

The Age-Related Eye Disease St ...... eneration: AREDS Report No. 17

@en

The Age-Related Eye Disease St ...... eneration: AREDS Report No. 17

@nl

type

label

The Age-Related Eye Disease St ...... eneration: AREDS Report No. 17

@ast

The Age-Related Eye Disease St ...... eneration: AREDS Report No. 17

@en

The Age-Related Eye Disease St ...... eneration: AREDS Report No. 17

@nl

prefLabel

The Age-Related Eye Disease St ...... eneration: AREDS Report No. 17

@ast

The Age-Related Eye Disease St ...... eneration: AREDS Report No. 17

@en

The Age-Related Eye Disease St ...... eneration: AREDS Report No. 17

@nl

P1433

Q34653094-DA959876-99E4-49D6-A88C-8B9A7A860627

P1476

Q34653094-13D98AA7-D021-4DB7-A83F-17CFDAD25602

P2093

Q34653094-4FA2A0B2-07F5-4467-84FB-6A6B5DED5FE5

Q34653094-564E698D-41AA-4E5B-80DA-26488B6BE942

Q34653094-798B9289-DD96-409E-8A6E-D11B648EDB9B

Q34653094-7FE43CF5-4740-40A0-949E-EC64DB12379C

Q34653094-8E9C955C-3801-47AA-A8C9-8EE4E5720F89

Q34653094-91E7E6FE-FBE5-43F2-90BA-7F68217FB8CB

Q34653094-A8CF0BEE-48D2-4F6E-A4D9-5D1B528710A1

Q34653094-C14A2F7B-9737-498D-B804-47FF007A2CF8

Q34653094-E865D8EE-CC9D-4ACF-94C7-47D2E15EC7E4

P2860

Q34653094-474812B1-44BC-4190-95D4-28DA3854C901

Q34653094-621EF752-E52F-4CC3-A303-76423F44A233

Q34653094-7B33D579-6313-414A-95A4-CF50C681EAA2

Q34653094-7D979EA4-EF84-4E58-948F-D6908CDBCECF

Q34653094-820F9ABD-4878-4F94-B661-5363C7C9F055

Q34653094-AB53D73F-7084-47A3-893D-014A2115F711

Q34653094-AFF96F24-3822-4426-A351-22610D0E08AB

Q34653094-E293B244-7D13-425C-B62D-4FA2B39AF497

P304

Q34653094-A1260020-CB1F-4723-938F-07FB742B29BC

P31

Q34653094-730E5962-CA13-4882-8547-F8BE4E09BF5F

P356

Q34653094-A87AD406-7437-4F9D-9307-08C3B44227B2

P407

Q34653094-BA9D7C16-8984-4ED4-820C-108092B2037F

P433

Q34653094-E486140B-EFD4-4918-892C-F2EE4C317B2A

P478

Q34653094-49EB2C8D-A548-4776-B568-00F3A46D7CC1

P50

Q34653094-530CF3E7-17BF-40B0-85D7-39C1848B82F9

P577

Q34653094-DE3535C5-95C5-47DA-AA64-F99FEFF58F20

P5875

Q34653094-78C0E31D-3251-42B9-8419-07BC64E4ED95

P698

Q34653094-5978FD1F-B834-46CB-98B6-6AAE64267790

P932

Q34653094-0BD4B58F-4BBC-4D5D-8233-31D4619D892E

P356

ARCHOPHT.123.11.1484

P1433

JAMA Ophthalmology

P1476

The Age-Related Eye Disease St ...... eneration: AREDS Report No. 17

@en

P2093

Age-Related Eye Disease Study Group

http://www.w3.org/2001/XMLSchema#string

Barbara E K Klein

http://www.w3.org/2001/XMLSchema#string

Frederick L Ferris

http://www.w3.org/2001/XMLSchema#string

Larry D Hubbard

http://www.w3.org/2001/XMLSchema#string

Li-Yin Lee

http://www.w3.org/2001/XMLSchema#string

Matthew D Davis

http://www.w3.org/2001/XMLSchema#string

Ronald Klein

http://www.w3.org/2001/XMLSchema#string

Roy C Milton

http://www.w3.org/2001/XMLSchema#string

Susan B Bressler

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6.

Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.

Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort.

The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study.

P304

1484-1498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHOPHT.123.11.1484

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Ronald E Gangnon

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7481070

http://www.w3.org/2001/XMLSchema#string

P698

16286610

http://www.w3.org/2001/XMLSchema#string

P932

1472813

http://www.w3.org/2001/XMLSchema#string